entertainment -WSS

entertainment

author：explore 2025-10-09 06:47:57 - browse：7618

Illustration of researchers working among oversized pill bottles, lab equipment, and medicine for story about the development of obesity medications – health and pharma coverage from STAT — Molly Ferguson for STAT

The exploding popularity of drugs like Wegovy and Mounjaro has propelled dozens of companies to develop their own obesity treatments, with most of them trying to emulate the same approach as the blockbuster products.

Nearly 70 obesity treatments are in development, and about two-thirds use a similar mechanism as Wegovy and Mounjaro, according to the STAT Obesity Drug Tracker, a new database compiled by STAT. There are also a minority of companies pursuing entirely different approaches, hoping that they will stand out among the field.

The tracker, which will be updated with significant developments each quarter, gives a sense of what new mechanisms could hit the market, how they would be delivered, and which companies are running the most trials.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Senate panel to vote on hospitals, PBMs, prisoner care

hotspot

WSS

Testing for cancer recurrence creates a new limbo for patients

Hospitals warn Medicare's drug payment fix is ‘unlawful’

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

Eyeing GLP

Questions and answers about ramping up H5N1 bird flu vaccine

Maker of FluMist seeks to allow at

focus

entertainment

hotspot

Bright Health sells Medicare Advantage business to Molina

Digital health: a case of mistaken identity

In Memoriam: Notable people who died in 2023

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

As demand for Covid shots wanes, Moderna seeks its next success

Digital health: a case of mistaken identity

Heart attack and stroke risk calculators need revising

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

Wildfire smoke exposes gaps in outdoor worker protections

Hospitals warn Medicare's drug payment fix is ‘unlawful’

entertainment

Cue Health, Covid

Telehealth options flood the market as retailers push virtual care

Liver decline slowed by off

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

FDA poised to publish guidelines for clinical trial diversity

Eyeing GLP

Wikipedia

entertainment

hotspot

explore